Abbott Laboratories (ABT) vs Bristol-Myers Squibb Company (BMY)
A side-by-side comparison of Abbott Laboratories and Bristol-Myers Squibb Company across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 13, 2026. Differences are shown without an overall score or investment verdict.
ABT
Abbott Laboratories
$102.04HealthcareDelayed quote: Sep 15, 2026, 10:30 AM EDT
BMY
Bristol-Myers Squibb Company
$63.52HealthcareDelayed quote: Sep 15, 2026, 10:30 AM EDT
Total return — ABT vs BMY
growth of $100 · dividends reinvested · last 10yABT +195.2% (+11.4%/yr)BMY +64.4% (+5.1%/yr)ABT compounded faster over this window
ABT BMY
ABT vs BMY: by the numbers
- •ABT is the larger company ($176.57B vs $129.75B market cap).
- •BMY trades at the lower trailing earnings multiple (13.99 vs 32.81 P/E), one valuation lens rather than an overall verdict.
- •BMY converts more revenue to profit (18.87% vs 11.65% net margin).
- •ABT grew revenue faster over the past five years (2.98% vs 2.08% CAGR).
- •BMY pays the higher dividend yield (3.94% vs 2.43%).
Metrics side by side
Valuation
| Metric | ABT | BMY |
|---|---|---|
| P/E ratio | 32.81 | 13.99 |
| Forward P/E | 18.50 | 9.17 |
| P/S ratio | 3.79 | 2.64 |
| P/B ratio | 3.45 | 5.81 |
| EV / EBITDA | 18.74 | 9.69 |
| FCF yield | 4.49% | 8.82% |
Profitability
| Metric | ABT | BMY |
|---|---|---|
| Gross margin | 56.80% | 70.16% |
| Operating margin | 17.03% | 28.27% |
| Net margin | 11.65% | 18.87% |
| ROE | 10.61% | 41.59% |
| ROIC | 6.07% | 15.47% |
Dividends
| Metric | ABT | BMY |
|---|---|---|
| Dividend yield | 2.43% | 3.94% |
| Payout ratio | 79.74% | 55.29% |
Growth (annualized)
| Metric | ABT | BMY |
|---|---|---|
| Revenue CAGR (5Y) | 2.98% | 2.08% |
| EPS CAGR (5Y) | 8.22% | 9.38% |
| FCF CAGR (5Y) | 0.18% | -0.95% |
| Total return CAGR (5Y) | -2.69% | 4.35% |
Frequently asked
- Which has the lower trailing P/E, ABT or BMY?
- BMY has the lower trailing P/E: ABT trades at 32.81 and BMY at 13.99. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, ABT or BMY?
- Over the past five years, ABT grew revenue faster — ABT at a 2.98% CAGR versus BMY at 2.08%.
- Does ABT or BMY pay a bigger dividend?
- ABT yields 2.43% and BMY yields 3.94% based on trailing dividends and the latest price.
- Is ABT or BMY more profitable?
- BMY runs the higher net margin — ABT at 11.65% versus BMY at 18.87%.
- How have ABT and BMY total returns compared?
- Over the past 10 years, ABT delivered 11.61% and BMY delivered 4.99% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Abbott Laboratories P/E ratioBristol-Myers Squibb P/E ratioAbbott Laboratories dividend yieldBristol-Myers Squibb dividend yieldAbbott Laboratories ROEBristol-Myers Squibb ROEAbbott Laboratories operating marginBristol-Myers Squibb operating marginAbbott Laboratories revenue growthBristol-Myers Squibb revenue growthAbbott Laboratories free cash flowBristol-Myers Squibb free cash flow
Abbott Laboratories & Bristol-Myers Squibb appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 13, 2026.